NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JMACCT ID: JMA-IIA00180

Registered date:02/06/2014

Multi-center prospective study about the clinical significance of the measurement of faecal calprotectin for inflammatory bowel disease.

Basic Information

Recruitment status Other
Health condition(s) or Problem(s) studiedinflammatory bowel diseases
Date of first enrollment06/02/2013
Target sample size180
Countries of recruitment
Study typeINTERVENTIONAL
Intervention(s)Intervention type:DEVICE. Intervention1:measurement of fecal calprotectin, Dose form:NOT APPLICABLE, Route of administration:NOT APPLICABLE . Control intervention1:person whom colonoscopy findings is normal..

Outcome(s)

Primary OutcomeFecal calprotectin, clinical activity index, endoscopic activity index(UC:sum of Mayo endoscopic subscore, CD:SES-CD).
Secondary OutcomeEvaluation of both fecal calprotectin and endoscopic activity as a predicting marker of relapse in patients with clinical remission of IBD.. Timepoint: one year after fecal calprotectin measurement and colonoscopy .

Key inclusion & exclusion criteria

Age minimum
Age maximumNo Limit
GenderBOTH
Include criteriaPatients with IBD who performed ileocolonoscopy
Exclude criteriaimcomplete colonoscopy, difficulty to collect fecal sample,stoma, and so on

Related Information

Contact

public contact
Name Kousaku Kawashima
Address Department of Internal Medicine II,89-1, Enya-cho, Izumo, Shimane, Japan
Telephone +81-853-20-2190
E-mail kk461223@med.shimane-u.ac.jp
Affiliation Shimane University School of Medicine
scientific contact
Name Kousaku Kawashima
Address Department of Internal Medicine II,89-1, Enya-cho, Izumo, Shimane, Japan
Telephone +81-853-20-2190
E-mail
Affiliation Shimane University School of Medicine